AnandRathi

Lincoln Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
614.35
+1.15 (+0.19%)

Lincoln Pharmaceuticals Ltd (Lincoln Pharma.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹1,231 crore.

Lincoln Pharmaceuticals Ltd Overview

Market cap₹1,231 Crs
Volume1,186
Prev. Close₹613.20
Year range₹439.95 - ₹770.00
Total Value₹7,28,619.10
ISININE405C01035

Lincoln Pharmaceuticals Ltd Fundamental Analysis

ROCE(TTM)15.18%
P/E Ratio (TTM)12.76
P/B Ratio1.62
Debt to Equity0.01
ROE11.60%
EPS (TTM)48.15
Dividend Yield0.29%
Book Value378.25
Profit Margin13.89%
Operating Margin12.45%

Lincoln Pharmaceuticals Ltd Historical Performance

1 Month Return5.83%
6 Month Return-3.68%
3 Year Return21.65%
3 Month Return-18.99%
1 Year Return13.46%
5 Year Return81.79%

Lincoln Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research